Published in Women's Health Weekly, January 6th, 2005
"The current regimens of hormone replacement therapy for postmenopausal women, estrogen combined with progestogen, have failed to show beneficial effects for the prevention of atherosclerotic disease. Although the relatively higher dose of estrogen contained in those regimens exerted adverse effects, there are few data examining a lower dose of estrogen in an atherosclerosis model," wrote T. Watanabe, University of Tokyo, and colleagues.
Thus, they "investigated experimentally whether lower doses of estrogen could inhibit neointimal formation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly